Zdrowie i gospodarka · 15/06/2009

FDA Clears 19 Drug Products for Sale, Citing Lack of Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has made a determination that 19 drug products, including THORAZINE (Chlorpromazine Hydrochloride) Injection, were not withdrawn from sale due to safety or effectiveness concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) for these products.